Terms ending in 2036
Every in-force patent on Precision Biosciences, Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,662,440 | Self-Limiting Viral Vectors Encoding Nucleases In force · High confidence | Precision Biosciences, Inc. | In force | High confidence | |
| US 10,758,595 | Treatment of Retinitis Pigmentosa Using Engineered Meganucleases In force · High confidence | Precision Biosciences, Inc. | In force | High confidence | |
| US 10,603,363 | Treatment of Retinitis Pigmentosa Using Engineered Meganucleases In force · High confidence | Precision Biosciences, Inc. | In force | High confidence | |
| US 9,889,160 | Genetically-Modified Cells Comprising a Modified Human T Cell Receptor Alpha Constant Region Gene In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | |
| US 9,889,161 | Genetically-Modified Cells Comprising a Modified Human T Cell Receptor Alpha Constant Region Gene In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | |
| US 9,950,010 | Genetically-Modified Cells Comprising a Modified Human T Cell Receptor Alpha Constant Region Gene In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | |
| US 9,950,011 | Genetically-Modified Cells Comprising a Modified Human T Cell Receptor Alpha Constant Region Gene In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | |
| US 9,969,975 | Genetically-Modified Cells Comprising a Modified Human T Cell Receptor Alpha Constant Region Gene In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | |
| US 9,993,501 | Genetically-Modified Cells Comprising a Modified Human T Cell Receptor Alpha Constant Region Gene In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | |
| US 9,993,502 | Genetically-Modified Cells Comprising a Modified Human T Cell Receptor Alpha Constant Region Gene In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | |
| 5 more term ends in 2036 · Pro | |||||
10 of 15 patents shown. Soonest term end first, then patent number.
Pro members see all 15.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.